Thomas Szekeres - Concepedia

Author

Thomas Szekeres

Also Known As

M Fritzer-Szekeres, M. Fritzer-Szekeres, M. Fritzer‐Szekeres, Szekeres, Szekeres, T, T Szekeres, T. Szekeres, THOMAS SZEKERES, Th. Szekeres, Thomas Szekeres

296

Publications

7.9K

Citations

H-Index

135

Concepts

All Affiliations

Medical University of Vienna University of Vienna Vienna General Hospital Ludwig Boltzmann Institute Applied Diagnostics Indiana University – Purdue University Indianapolis

About

Thomas Szekeres is an author at Medical University of Vienna specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	77	3K
2	Natural Sciences	13	14	632
3	Public Health	3	3	131
4	Health Sciences	2	2	92
5	Education	1	1	11

Thomas Szekeres

131

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial Rupert Bartsch, Anna S. Berghoff, Julia Furtner, Nature Medicine	2022	374
Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure–activity relationship Marek Murias, Walter Jäger, Norbert Handler, Biochemical Pharmacology Structure–activity RelationshipBiochemistryMedicinePhytochemicalResveratrol Analogues	2005	298
Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure–activity relationship Marek Murias, Norbert Handler, Thomas Erker, Bioorganic & Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	2004	284
Four‐year study of cobalt and chromium blood levels in patients managed with two different metal‐on‐metal total hip replacements Christian Lhotka, Thomas Szekeres, Ilse Steffan, Journal of Orthopaedic Research®	2003	245
Mode of delivery is associated with maternal and fetal endocrine stress response SE Vogl, Christof Worda, Christian Egarter, BJOG An International Journal of Obstetrics & Gynaecology	2006	189
Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells Sibylle Madlener, Christoph Illmer, Zsuzsanna Bagó-Horváth, Cancer Letters OxysterolBiochemistryMedicineLipid PeroxidationInhibits Ribonucleotide Reductase	2006	142
The predictive value of MDR1, CYP2C9, and CYP2C19 polymorphisms for phenytoin plasma levels Reinhold Kerb, A.S. Aynacioglu, Jürgen Brockmöller, The Pharmacogenomics Journal Phenytoin Plasma LevelsMedicineGeneticsPharmacologyGenetic Epidemiology	2001	133
Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume Christopher Adlbrecht, Spyridoula Kommata, Martin Hülsmann, European Heart Journal	2008	121
N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients* Brigitte Meyer, M Huelsmann, Paul Wexberg, Critical Care Medicine	2007	99
Sulfation of resveratrol in human liver: Evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1 Michaela Miksits, Alexandra Maier‐Salamon, Sylvia Aust, Xenobiotica	2005	96

Page 1